METTL3 and metabolic dysfunction-associated steatotic liver disease: To validate the function of METTL3 in NAFLD-HCC, we next established Mettl3 heterozygous knockout (Mettl3+/−) mice (Figure 3A), which did not affect CD8+ T cell proliferation and function (Figures S3A–S3E).